Annovis Bio, Inc. (ANVS) — DEF 14A Filings
All DEF 14A filings from Annovis Bio, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Annovis Bio Files Proxy Statement for June Meeting
— Apr 30, 2025 Risk: medium
Annovis Bio, Inc. filed its definitive proxy statement on April 30, 2025, for its annual meeting on June 17, 2025. The company, formerly known as QR Pharma, Inc -
Annovis Bio, Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 29, 2024 Risk:
Annovis Bio, Inc. (ANVS) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Annovis Bio, Inc. will hold its 2024 Annual Meeting of Stockholders o
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX